Ma et al. investigated tumor biopsies from patients treated with BRAF inhibitors or combined BRAF/MEF inhibitors and found that tumors with resistance to BRAF inhibitors had increased levels of autophagy relative to the baseline [52]. The gene discussed is BRAF; the disease is neoplasm.